Literature DB >> 11163436

The CYC3 gene of trypanosoma brucei encodes a cyclin with a short half-life.

J J Van Hellemond1, J C Mottram.   

Abstract

Recently, we identified two Trpanosoma brucei cyclin genes, CYC2 and CYC3, by rescue of the Saccharomyces cerevisiae mutant DL1, which is deficient in CLN G1 cyclin function. CYC3 has a low level of sequence identity to mitotic B-type cyclins from a variety of organisms. In order to examine whether CYC3 associates in vivo with a trypanosome cdc2-related kinase (CRK), the CYC3 gene was fused with the TY-epitope tag, integrated into the trypanosome genome and expressed under inducible control. CYC3ty was demonstrated to associate with the CRK-binding factor p12cks1 and histone H1 kinase activity could be detected in CYC3ty immune precipitated fractions, which demonstrates that CYC3ty associates in vivo with an active trypanosome CRK. Both CYC3ty and CYC2ty were shown to have a half-life of less than one cell cycle, which was significantly elongated by specific proteasome inhibitors, strongly suggesting that CYC3ty and CYC2ty are substrates for proteasome degradation. This is consistent with the presence in CYC3 of a putative destruction box motif that defines proteins for degradation via the ubiquitin degradation pathway. These results are consistant with proteolysis by the proteasome being involved in regulation of the cellular cyclin concentration in trypanosomes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11163436     DOI: 10.1016/s0166-6851(00)00318-2

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  9 in total

1.  The cooperative roles of PHO80-like cyclins in regulating the G1/S transition and posterior cytoskeletal morphogenesis in Trypanosoma brucei.

Authors:  Yi Liu; Huiqing Hu; Ziyin Li
Journal:  Mol Microbiol       Date:  2013-08-16       Impact factor: 3.501

2.  Inhibition of proteasome activity blocks Trypanosoma cruzi growth and metacyclogenesis.

Authors:  Josiane Cardoso; Maurilio J Soares; Rubem F S Menna-Barreto; Rozenn Le Bloas; Vanessa Sotomaior; Samuel Goldenberg; Marco A Krieger
Journal:  Parasitol Res       Date:  2008-06-26       Impact factor: 2.289

3.  Surface proteins, ERAD and antigenic variation in Trypanosoma brucei.

Authors:  Calvin Tiengwe; Katherine A Muratore; James D Bangs
Journal:  Cell Microbiol       Date:  2016-07-01       Impact factor: 3.715

Review 4.  Role of the Ubiquitin-Proteasome Systems in the Biology and Virulence of Protozoan Parasites.

Authors:  Christian Muñoz; Juan San Francisco; Bessy Gutiérrez; Jorge González
Journal:  Biomed Res Int       Date:  2015-05-19       Impact factor: 3.411

5.  Proteome turnover in the bloodstream and procyclic forms of Trypanosoma brucei measured by quantitative proteomics.

Authors:  Michele Tinti; Maria Lucia S Güther; Thomas W M Crozier; Angus I Lamond; Michael A J Ferguson
Journal:  Wellcome Open Res       Date:  2019-10-09

Review 6.  Ubiquitination and the Proteasome as Drug Targets in Trypanosomatid Diseases.

Authors:  Marie-José Bijlmakers
Journal:  Front Chem       Date:  2021-01-28       Impact factor: 5.221

7.  Genome-scale RNA interference profiling of Trypanosoma brucei cell cycle progression defects.

Authors:  Catarina A Marques; Melanie Ridgway; Michele Tinti; Andrew Cassidy; David Horn
Journal:  Nat Commun       Date:  2022-09-10       Impact factor: 17.694

8.  Chaperone requirements for biosynthesis of the trypanosome variant surface glycoprotein.

Authors:  Mark C Field; Tatiana Sergeenko; Ya-Nan Wang; Susanne Böhm; Mark Carrington
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

9.  The cooperative roles of two kinetoplastid-specific kinesins in cytokinesis and in maintaining cell morphology in bloodstream trypanosomes.

Authors:  Ying Wei; Huiqing Hu; Zhao-Rong Lun; Ziyin Li
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.